A Curable Disease That Keeps Killing
Why does a country that has cut its tuberculosis incidence rate by almost two-thirds in a decade still bury tens of thousands of TB patients every year? That is the question raised by the World Health Organization’s latest estimates for South Africa, published this week alongside the Global Tuberculosis Report 2026.
According to the WHO, an estimated 235,000 people in South Africa fell ill with TB in 2025, and about 53,000 died of it. The country’s TB incidence rate has fallen by 63 percent since 2015. The absolute number of annual TB deaths, however, has fallen by only 19 percent over the same period. Fewer people are getting sick, but those who do are still dying at a stubbornly high rate.
HIV and Drug Resistance Shape the Toll
South Africa’s TB epidemic remains bound up with HIV. Of the 235,000 people who developed TB in 2025, an estimated 139,000 were living with HIV. Of the 53,000 deaths, just over half, about 27,000, were among people with HIV. The WHO also estimates 14,000 cases of drug-resistant TB in the country last year, a form of the disease that is harder, slower and more expensive to treat.
These figures matter beyond South Africa’s borders. The region’s mining labor systems, cross-border migration and high HIV prevalence have long tied TB control in one country to its neighbors. A slow decline in deaths in the region’s largest economy is a warning for health systems across Southern Africa.
Three Counts, Three Different Pictures
The numbers depend heavily on who is counting. Thembisa, the leading mathematical model of HIV and TB in South Africa, estimates that 306,000 people aged 15 and older fell ill with TB in 2025, well above the WHO’s 235,000 for all ages. On deaths, the two are close: Thembisa also estimates 53,000 TB deaths in 2025, though only for adults and older teenagers.
Both model estimates are more than double the figure from Statistics South Africa, which recorded just under 19,000 TB deaths in 2024. The difference is not surprising. The WHO and Thembisa produce modeled estimates, while the national statistics agency counts what is written on death notifications, and there is good evidence that some conditions are systematically under-reported on those forms. The WHO itself stresses that its incidence figure is very uncertain: its 95 percent uncertainty range runs from 148,000 to 342,000. The 235,000 figure also counts only people who first fell ill in 2025; many who fell ill in 2024 were still sick last year, so the total number of people living with TB in 2025 was higher.
The Missing Cases May Not Be Gone
For years, health workers have worried about the “missing cases”: people who fall ill with TB but are diagnosed late or never. South Africa diagnoses roughly 200,000 people a year. As the WHO’s estimate of total cases has dropped from more than 300,000 to 235,000, the apparent gap has narrowed to about 35,000, far below estimates of more than 100,000 just five years ago.
It would be premature to declare the problem solved. The WHO’s range is wide, and Thembisa’s estimate is much higher. A recent modeling study found that many people who arrive at public clinics with TB symptoms are not offered a TB test. The classic symptoms- a persistent cough, night sweats, fatigue, chest pain, fever, and unexplained weight loss- are well known. The modeling suggests that testing more of the people who already walk into clinics with those symptoms is one of the most effective steps the country could take.
A Global Milestone, Reached Late
Globally, the WHO estimates that 10.6 million people fell ill with TB in 2025 and 1.1 million died. Only 8.4 million were diagnosed, leaving about 2.2 million undiagnosed or unreported. The agency says deaths have fallen by 35 percent since 2015 and that treatment has saved an estimated 86 million lives since 2000, meaning the world has reached the first mortality milestone of its End TB Strategy, five years later than planned. The global incidence rate has fallen by only 14 percent since 2015, far short of the 50 percent target for 2025, and TB remains the leading cause of death from a single infectious agent.
“The continued decline in TB cases and deaths is very encouraging, especially given the challenges many countries have faced from funding cuts,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “Many governments have dug deeper into their own budgets to protect the gains they have made. And yet, more than one million people still die each year from a disease that is preventable and treatable.”
Paying for Our Own Cure
Tedros’s point about governments digging into their own budgets is the heart of the matter for African health systems. As external health funding shrinks, the countries that keep their gains will be those that treat TB testing and treatment as core public spending rather than a donor project. South Africa has the laboratories, the clinics and the research base to close the gap between falling infections and stubborn deaths. What it needs is the will to test everyone who presents with symptoms, to count deaths accurately, and to fund that work from its own resources. A disease that is preventable and curable should not remain one of the country’s biggest killers.

